Rigel Pharmaceuticals, Inc. (RIGL)
48.22
+0.72
(+1.52%)
USD |
NASDAQ |
Sep 02, 10:40
Rigel Pharmaceuticals Net Income (TTM) : 321.91M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 321.91M |
| March 31, 2026 | 364.23M |
| December 31, 2025 | 367.02M |
| September 30, 2025 | 113.30M |
| June 30, 2025 | 97.82M |
| March 31, 2025 | 37.18M |
| December 31, 2024 | 17.48M |
| September 30, 2024 | 3.881M |
| June 30, 2024 | -14.23M |
| March 31, 2024 | -19.80M |
| December 31, 2023 | -25.09M |
| September 30, 2023 | -24.43M |
| June 30, 2023 | -37.77M |
| March 31, 2023 | -44.66M |
| December 31, 2022 | -58.57M |
| September 30, 2022 | -82.62M |
| June 30, 2022 | -84.53M |
| March 31, 2022 | -84.86M |
| December 31, 2021 | -17.91M |
| September 30, 2021 | -14.51M |
| June 30, 2021 | -7.732M |
| March 31, 2021 | -11.49M |
| December 31, 2020 | -29.74M |
| September 30, 2020 | -27.71M |
| June 30, 2020 | -25.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -28.05M |
| December 31, 2019 | -66.89M |
| September 30, 2019 | -46.47M |
| June 30, 2019 | -58.74M |
| March 31, 2019 | -63.69M |
| December 31, 2018 | -70.48M |
| September 30, 2018 | -99.58M |
| June 30, 2018 | -93.47M |
| March 31, 2018 | -87.06M |
| December 31, 2017 | -77.99M |
| September 30, 2017 | -67.71M |
| June 30, 2017 | -72.68M |
| March 31, 2017 | -67.07M |
| December 31, 2016 | -69.22M |
| September 30, 2016 | -66.31M |
| June 30, 2016 | -50.36M |
| March 31, 2016 | -50.74M |
| December 31, 2015 | -51.46M |
| September 30, 2015 | -61.05M |
| June 30, 2015 | -75.32M |
| March 31, 2015 | -86.80M |
| December 31, 2014 | -90.91M |
| September 30, 2014 | -85.50M |
| June 30, 2014 | -88.38M |
| March 31, 2014 | -85.76M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 129.87M |
| Cytokinetics, Inc. | -894.00M |
| Perspective Therapeutics, Inc. | -116.63M |
| Capricor Therapeutics, Inc. | -129.42M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |